VICTORIA Study: Larotrectinib vs Traditional SoC Efficacy Highlights
Due to the involvement of NTRK gene fusions in various tumors, their occurrence is rare, and the standard therapies (SoC) and prognoses for different tumors vary. Conducting clinical trials of TRK inhibitors using the “gold standard” randomized controlled trials (RCTs) is often impractical. Currently, clinical trials for TRK inhibitors mostly employ single-arm basket study designs … Read more